{"news_desk": "National", "print_page": "20", "subsection_name": null, "section_name": "Health", "byline": {"original": "By GINA KOLATA", "person": [{"firstname": "Gina", "rank": 1, "lastname": "KOLATA", "organization": "", "role": "reported"}]}, "abstract": null, "type_of_material": "News", "word_count": "1113", "keywords": [{"rank": "1", "value": "Cholesterol", "is_major": "Y", "name": "subject"}, {"rank": "2", "value": "Health Insurance and Managed Care", "is_major": "Y", "name": "subject"}, {"rank": "3", "value": "Drugs (Pharmaceuticals)", "is_major": "Y", "name": "subject"}, {"rank": "4", "value": "Journal of the American Medical Assn", "is_major": "N", "name": "organizations"}, {"rank": "5", "value": "Nissen, Steven E", "is_major": "N", "name": "persons"}, {"rank": "7", "value": "Heart", "is_major": "N", "name": "subject"}, {"rank": "8", "value": "Statins (Cholesterol-Lowering Drugs)", "is_major": "N", "name": "subject"}], "lead_paragraph": "A study of so-called PCSK9 inhibitors showed they can reduce the size of plaques in arteries that may cause heart attacks, a signal that they will show benefit in reducing heart attack risk.", "pub_date": "2016-11-15T16:46:37Z", "document_type": "article", "source": "The New York Times", "snippet": "A study of so-called PCSK9 inhibitors showed they can reduce the size of plaques in arteries that may cause heart attacks, a signal that they will show benefit in reducing heart attack risk....", "multimedia": [{"height": 126, "subtype": "wide", "legacy": {"widewidth": "190", "wide": "images/2016/11/16/science/15HEART/15HEART-thumbWide.jpg", "wideheight": "126"}, "type": "image", "width": 190, "url": "images/2016/11/16/science/15HEART/15HEART-thumbWide.jpg"}, {"height": 400, "subtype": "xlarge", "legacy": {"xlargewidth": "600", "xlargeheight": "400", "xlarge": "images/2016/11/16/science/15HEART/15HEART-articleLarge.jpg"}, "type": "image", "width": 600, "url": "images/2016/11/16/science/15HEART/15HEART-articleLarge.jpg"}, {"height": 75, "subtype": "thumbnail", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2016/11/16/science/15HEART/15HEART-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "url": "images/2016/11/16/science/15HEART/15HEART-thumbStandard.jpg"}], "web_url": "http://www.nytimes.com/2016/11/16/health/cholesterol-drugs-pcsk9-inhibitors.html", "slideshow_credits": null, "blog": [], "_id": "582b3bf37c459f6a5fcce1b3", "headline": {"main": "Study Shows Promise for Expensive Cholesterol Drugs, but They Are Still Hard to Obtain", "print_headline": "Study Shows Promise for Costly Cholesterol Drugs, but They Remain Hard to Obtain"}}